STOCK TITAN

Sintx Technologies Inc Stock Price, News & Analysis

SINT Nasdaq

Welcome to our dedicated page for Sintx Technologies news (Ticker: SINT), a resource for investors and traders seeking the latest updates and insights on Sintx Technologies stock.

SINTX Technologies Inc (SINT) delivers cutting-edge advanced ceramics solutions for critical biomedical and industrial applications through its silicon nitride expertise. This news hub provides investors and industry professionals with essential updates on the company’s material science innovations, regulatory milestones, and market developments.

Access real-time announcements covering earnings reports, product launches, strategic partnerships, and research breakthroughs in antimicrobial ceramics technology. Our curated collection simplifies tracking SINTX’s progress in spinal implant advancements, industrial material innovations, and antipathogenic surface solutions.

Key updates across three focus areas: Medical Device Developments (FDA-cleared implants, clinical trial results), Technical Ceramics Innovation (3D printing materials, industrial components), and Corporate Strategy (partnerships, financial performance). Bookmark this page for streamlined monitoring of SINTX’s role in advancing ceramics technology across healthcare and manufacturing sectors.

Rhea-AI Summary

SINTX Technologies (NASDAQ: SINT) has announced it has regained compliance with NASDAQ's minimum bid price requirements. The company confirmed that its common stock closed at $1.00 or more per share for ten consecutive business days, from December 20, 2022, to January 4, 2023. This compliance with Listing Rule 5550(a)(2) means the previous issue is now resolved. SINTX is known for developing advanced ceramics for medical and technical applications, and its products have been in human use since 2008.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.24%
Tags
none
-
Rhea-AI Summary

SINTX Technologies has secured a Phase I contract worth $150K from the U.S. Missile Defense Agency to enhance electrochemical machining (ECM) for aerospace components. This project focuses on developing corrosion-resistant, dielectric coatings aimed at extending tool life and reducing machining costs. Collaborating with Voxel Innovations, SINTX plans to scale up this technology for prototype development after successful contract completion. The U.S. micromachining market is growing, projected at $2.5 billion in 2019, with the non-traditional machining segment, including ECM, leading market advances.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
57.16%
Tags
none
-
Rhea-AI Summary

SINTX Technologies announces a 1-for-100 reverse stock split for its common stock effective on December 20, 2022. This action aims to meet Nasdaq's minimum bid price requirements. Following the split, every 100 shares will convert to one new share, with adjustments to the exercise prices and shares underlying existing securities. This change will not impact stockholders’ percentage interests, except for fractional shares, which will be rounded up. The company retains its current trading symbol, SINT.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.27%
Tags
none
Rhea-AI Summary

SINTX Technologies has received a $1.5 million Phase II award from the Defense Advanced Research Projects Agency (DARPA) to develop thermal-environmental barrier coatings for high-temperature ceramic matrix composites (CMCs). This project aims to enable gas turbines to operate at up to 3,100°F, addressing lifetime issues in turbine components. The initiative promises improved performance and reduced maintenance costs for both military and commercial applications, along with significant societal benefits such as energy savings and lower emissions.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.8%
Tags
none
-
Rhea-AI Summary

SINTX Technologies, Inc. (NASDAQ: SINT) announced preliminary results of its rights offering, which ended on October 12, 2022, with approximately $4.7 million in total subscriptions. Each right allowed the purchase of one unit for $1,000, which includes one share of Series D Convertible Preferred Stock and two classes of warrants, all convertible to common stock at $0.1510 per share. The offering is expected to close around October 17, 2022, pending conditions. The press release emphasizes the Company’s focus on advanced ceramics for medical applications, including silicon nitride products utilized since 2008.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-8.33%
Tags
none
-
Rhea-AI Summary

SINTX Technologies, Inc. (NASDAQ: SINT) has received a production order for silicon nitride components from a global aerospace manufacturer. This follows a rigorous qualification process assessing SINTX's Operational and Quality Management Systems. The company's certified AS9100D manufacturing process enabled it to meet strict customer requirements. SINTX's STX-100 silicon nitride offers high strength and durability, making it ideal for aerospace applications. The company anticipates further orders as it expands in the aerospace market, leveraging its existing capabilities in Salt Lake City.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.03%
Tags
none
Rhea-AI Summary

SINTX Technologies has announced the awarding of four new international patents for antibacterial biomedical implants. These patents, granted in Canada, Australia (two patents), and Japan, enhance SINTX's intellectual property portfolio surrounding silicon nitride, a bioceramic noted for its bacteriostatic properties. The company aims to provide more value to its medical device partners, addressing significant healthcare issues related to infections. SINTX has also expanded through acquisitions, recently incorporating new ceramic materials into its offerings.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-7.33%
Tags
none
-
Rhea-AI Summary

SINTX Technologies has received a $275k Phase I grant from the National Institutes of Health (NIH) to develop an antimicrobial trauma device. This 3D printed device will feature a carbon fiber reinforced polyetherketoneketone (PEKK) plate with embedded silicon nitride, enhancing its antibacterial properties. Collaborating with Drexel University and others, SINTX aims to address high infection rates in orthopedic trauma procedures. Successful development may lead to a Phase II award for commercialization. This marks NIH's third grant to SINTX within a year.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.23%
Tags
none
-
Rhea-AI Summary

SINTX Technologies, Inc. (NASDAQ: SINT) announced a Phase II award of $1.1 million from the U.S. Department of Energy to develop 3D-printed alumina ceramic heat exchangers for HVAC systems. This award follows a successful Phase I effort by the company's subsidiary, Technology Assessment and Transfer (TA&T). The project aims to enhance energy efficiency in heating systems, boasting features such as lighter weight and superior thermal conductivity compared to conventional materials. Collaboration with the University of Cincinnati and Carrier is integral to advancing commercialization efforts.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.31%
Tags
none
Rhea-AI Summary

SINTX Technologies, Inc. (NASDAQ: SINT) has announced the commencement of its rights offering subscription period, which has been extended to October 12, 2022. Each right allows the purchase of one unit at a subscription price of $1,000, including shares of Series D Convertible Preferred Stock and warrants. Maxim Group LLC is appointed as dealer-manager for this offering. The registration statement for this rights offering was declared effective by the SEC on September 23, 2022. Investors are advised to contact their brokers for participation details.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-16.75%
Tags
none

FAQ

What is the current stock price of Sintx Technologies (SINT)?

The current stock price of Sintx Technologies (SINT) is $2.71 as of May 5, 2025.

What is the market cap of Sintx Technologies (SINT)?

The market cap of Sintx Technologies (SINT) is approximately 6.2M.
Sintx Technologies Inc

Nasdaq:SINT

SINT Rankings

SINT Stock Data

6.16M
2.24M
1.62%
4.31%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
SALT LAKE CITY